Equifax (NYSE:EFX – Get Free Report) had its price objective dropped by research analysts at Needham & Company LLC from $325.00 to $300.00 in a research report issued on Friday,Benzinga reports. The firm currently has a “buy” rating on the credit services provider’s stock. Needham & Company LLC’s target price suggests a potential upside of 21.44% from the stock’s previous close.
Several other research firms have also recently issued reports on EFX. Morgan Stanley cut their price objective on shares of Equifax from $320.00 to $316.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Stifel Nicolaus cut their price target on shares of Equifax from $305.00 to $284.00 and set a “buy” rating for the company in a report on Wednesday, November 20th. Wells Fargo & Company decreased their price objective on Equifax from $321.00 to $313.00 and set an “overweight” rating on the stock in a report on Monday. Robert W. Baird increased their price objective on Equifax from $290.00 to $333.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Finally, Jefferies Financial Group reduced their target price on Equifax from $340.00 to $300.00 and set a “buy” rating on the stock in a research report on Wednesday, January 15th. Two investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $307.47.
Read Our Latest Stock Analysis on EFX
Equifax Trading Down 8.6 %
Equifax (NYSE:EFX – Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The credit services provider reported $2.12 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.12. Equifax had a return on equity of 18.56% and a net margin of 10.07%. Analysts predict that Equifax will post 7.27 EPS for the current fiscal year.
Insider Transactions at Equifax
In related news, EVP Lisa M. Nelson sold 551 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $260.39, for a total value of $143,474.89. Following the transaction, the executive vice president now owns 11,697 shares of the company’s stock, valued at $3,045,781.83. This represents a 4.50 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 1.66% of the company’s stock.
Institutional Investors Weigh In On Equifax
Institutional investors have recently added to or reduced their stakes in the business. Ashton Thomas Securities LLC purchased a new position in Equifax in the third quarter valued at approximately $29,000. McClarren Financial Advisors Inc. acquired a new position in shares of Equifax in the 4th quarter valued at $25,000. Central Pacific Bank Trust Division purchased a new position in shares of Equifax in the 4th quarter valued at $35,000. Spire Wealth Management raised its stake in Equifax by 98.7% during the 4th quarter. Spire Wealth Management now owns 151 shares of the credit services provider’s stock worth $38,000 after acquiring an additional 75 shares in the last quarter. Finally, Exchange Traded Concepts LLC purchased a new stake in Equifax in the third quarter valued at $48,000. Hedge funds and other institutional investors own 96.20% of the company’s stock.
About Equifax
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Recommended Stories
- Five stocks we like better than Equifax
- Short Selling – The Pros and Cons
- Uber’s Business, Cash Flow, and AI are Why it Will Set a New High
- What Is WallStreetBets and What Stocks Are They Targeting?
- Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
- What is an Earnings Surprise?
- These are the 3 Stocks Most Likely to Split in 2025
Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.